Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

Granulocyte colony‐stimulating factor (G‐CSF) has been used to restore immune competence following chemoablative cancer therapy and to promote immunological tolerance in certain settings of autoimmunity. Therefore, we tested the potential of G‐CSF to impact type 1 diabetes (T1D) progression in patie...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Exp Immunol
Glavni autori: Haller, M. J., Atkinson, M. A., Wasserfall, C. H., Brusko, T. M., Mathews, C. E., Hulme, M., Cintron, M., Shuster, J., McGrail, K., Posgai, A., Schatz, D.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750600/
https://ncbi.nlm.nih.gov/pubmed/26462724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12731
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items